Biotech

All Articles

Daiichi pays for Merck $170M to form bronchi cancer cells T-cell engager pact

.Merck &amp Co. has quickly recovered several of the expenses of its Spear Therapeutics purchase, at...

BioMarin halts preclinical gene treatment for heart condition

.After BioMarin administered a spring season clean of its pipeline in April, the business has determ...

Eisai plants molecular glue SEED with $1.5 B biobucks work

.Big Pharmas remain stuck to the suggestion of molecular glue degraders. The current firm to observe...

Life science debt company introduces with $600M

.A brand-new worldwide lifestyle science credit report firm, referred to Symbiotic Financing, has br...

BMS channels TIGIT, leaving $200M bank on Agenus bispecific

.Bristol Myers Squibb is actually axing an additional large wager coming from the Caforio era, endin...

Nuvation halts BET inhibitor after looking at stage 1 record

.After taking a look at phase 1 data, Nuvation Bio has decided to stop focus on its own one-time lea...

' Medical instinct' led FDA consultants to back Zevra's unusual ailment med

.Zevra Rehabs' uncommon disease medication appears to become on the path to authorization this autum...

Pfizer takes $230M hit after axing fell short DMD gene treatment

.Pfizer's phase 3 Duchenne muscular dystrophy (DMD) genetics therapy failure has actually blown a $2...

AC Immune sees 'site' potential in Alzheimer's medicine information

.After much more than two decades of work on neurodegenerative ailments, Swiss biotech AC Immune cla...

GSK drops ph. 2 HPV vaccination over absence of best-in-class prospective

.GSK has junked a stage 2 individual papillomavirus (HPV) vaccine from its pipeline after determinin...